Picture of Zeria Pharmaceutical logo

4559 — Zeria Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareConservativeMid CapNeutral

Table: Zeria Pharm - 9-MTH group results

Feb 6 (Reuters)-  
             Zeria Pharmaceutical Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2017        Dec 31, 2016     Mar 31, 2018  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             49.64               49.04            66.00     
                 (+1.2 pct)          (+4.2 pct)       (+1.8 pct)   
  Operating          4.59                3.64             5.00     
                 (+26.0 pct)         (-4.0 pct)       (+10.1 pct)  
  Recurring          4.89                3.50             5.20     
                 (+39.6 pct)         (-7.0 pct)       (+17.2 pct)  
  Net                3.96                2.87             4.10     
                 (+37.6 pct)         (-13.8 pct)      (+15.7 pct)  
  EPS             76.35 yen           54.10 yen        79.53 yen   
  Ann Div                             32.00 yen        34.00 yen   
  -Q2 div         17.00 yen           16.00 yen                    
  -Q4 div                             16.00 yen        17.00 yen   
   
  NOTE - Zeria Pharmaceutical Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4559.T 
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Zeria Pharmaceutical

See all news